BP5 | The percentage of patients with hypertension in whom the last blood pressure (measured in last 9 months) is 150/90 mmHg or less | 56 | 8.35 | 71.3 | Indicative15 | 989 |
|
CHD9 | The percentage of patients with CHD with a record in the last 15 months that aspirin, an alternative antiplatelet therapy, or an anticoagulant is being taken (unless a contraindication or side-effects are recorded) | 7 | 2.64 | 90.0 | Robust16 | Dominant (less costly and more effective than comparator)b |
|
CHD10 | The percentage of patients with CHD who are currently treated with a beta-blocker (unless a contraindication or side-effects are recorded) | 7 | 4.77 | 63.2 | Indicative17 | 58 |
|
CHD11 | The percentage of patients with a history of myocardial infarction (diagnosed after 1 April 2003) who are currently treated with an ACE inhibitor | 7 | 40.61 | 85.6 | Robust18 | 5623 |
|
CS1 | The percentage of patients aged 25–64 years (in Scotland 25–60 years) whose notes record that a cervical smear has been performed in the last 3 to 5 years | 11 | 0.63 | 80.2 | Indicative19 | 458 |
|
DM15 | The percentage of patients with diabetes with proteinuria or micro-albuminuria who are treated with ACE inhibitors (or A2 antagonists) | 3 | 17.86 | 82.1 | Indicative20 | Dominantb |
|
DM21 | The percentage of patients with diabetes who have a record of retinal screening in the previous 15 months | 5 | 1.97 | 83.2 | Robust21 | 15 654 |
|
LVD3 | The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or or A2 antagonist, who can tolerate therapy and for whom there is no contraindication | 10 | 36.25 | 82.1 | Indicative22 | 109 |
|
Stroke12 | The percentage of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an antiplatelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anticoagulant is being taken (unless a contraindication or side-effects are recorded) | 4 | 6.00 | 89.3 | Robust16 | 2012 |